STOCK TITAN

Nextdoor director Varelas sells 41,196 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

On November 13, 2026, Nextdoor Holdings, Inc. director Christopher Varelas exercised options for 41,196 Class A shares at exercise prices of $1.61, $1.64, $1.74, $1.76 and $1.77, then sold those shares at $2.0056 per share. Separately, 175,334 shares held for the benefit of entities affiliated with Riverwood Capital GP II Ltd. were sold at a weighted-average $2.0061 per share, with transaction prices from $1.99 to $2.045 inclusive. Varelas disclaimed beneficial ownership of those securities except to the extent of any pecuniary interest; no Rule 10b5-1 plan is reported.

Insider Varelas Christopher
Role Director
Sold 216,530 shs ($434K)
Approx. gross sale proceeds $434K
Approx. exercise cost $70K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 8,240 $0.00 $0.00
Exercise Stock Option (Right to Buy) 8,239 $0.00 $0.00
Exercise Stock Option (Right to Buy) 8,239 $0.00 $0.00
Exercise Stock Option (Right to Buy) 8,239 $0.00 $0.00
Exercise Stock Option (Right to Buy) 8,239 $0.00 $0.00
Sale Class A Common Stock F1, F2 175,334 $2.0061 $352K
Exercise Class A Common Stock 8,240 $1.64 $14K
Sale Class A Common Stock F3 8,240 $2.0056 $17K
Exercise Class A Common Stock 8,239 $1.76 $15K
Sale Class A Common Stock F3 8,239 $2.0056 $17K
Exercise Class A Common Stock 8,239 $1.77 $15K
Sale Class A Common Stock F3 8,239 $2.0056 $17K
Exercise Class A Common Stock 8,239 $1.74 $14K
Sale Class A Common Stock F3 8,239 $2.0056 $17K
Exercise Class A Common Stock 8,239 $1.61 $13K
Sale Class A Common Stock F3 8,239 $2.0056 $17K
Holdings After Transaction: Stock Option (Right to Buy) — 0 options (Direct); Class A Common Stock — 0 shares (Direct)
Footnotes (3)
  1. F1. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.99 to $2.045 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. F2. These securities are held by Mr. Varelas for the benefit of one or more entities affiliated with Riverwood Capital GP II Ltd. (collectively, "Riverwood"). Mr. Varelas is obligated to transfer such securities (or, in the case of an equity award, the shares underlying such award) or any proceeds from the sale thereof as directed by Riverwood. Mr. Varelas disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities by Mr. Varelas for purposes of Section 16 or any other purposes.
  3. F3. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.99 to $2.040 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Options exercised 41,196 Class A shares By director Christopher Varelas on November 13, 2026
Exercise prices $1.61, $1.64, $1.74, $1.76 and $1.77 per share Options exercised on November 13, 2026
Sale price of exercise shares $2.0056 per share Class A shares sold on November 13, 2026
Riverwood-affiliated entity shares sold 175,334 shares Shares held for the benefit of entities affiliated with Riverwood Capital GP II Ltd.
Weighted-average sale price $2.0061 per share Riverwood-affiliated entity shares; individual transaction prices ranged from $1.99 to $2.045
weighted average price financial
"The reported price is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
exercise price financial
"conversion_or_exercise_price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
pecuniary interest regulatory
"except to the extent of any pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NXDR shares did director Christopher Varelas sell after exercising options?

On November 13, 2026, director Christopher Varelas exercised options for 41,196 Class A shares at exercise prices of $1.61, $1.64, $1.74, $1.76 and $1.77 per share, then sold those shares at $2.0056 per share. No Rule 10b5-1 plan is reported.

How many NXDR shares were sold for Riverwood-affiliated entities?

Entities affiliated with Riverwood Capital GP II Ltd. sold 175,334 shares held for their benefit on November 13, 2026, at a weighted-average price of $2.0061 per share; individual transaction prices ranged from $1.99 to $2.045. Christopher Varelas disclaimed beneficial ownership except to the extent of any pecuniary interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Varelas Christopher

(Last)(First)(Middle)
C/O NEXTDOOR HOLDINGS, INC.
420 TAYLOR STREET

(Street)
SAN FRANCISCO CALIFORNIA 94102

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nextdoor Holdings, Inc. [ NXDR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock11/13/2026S175,334D$2.0061(1)0D(2)
Class A Common Stock11/13/2026M8,240A$1.648,240D
Class A Common Stock11/13/2026S8,240D$2.0056(3)0D
Class A Common Stock11/13/2026M8,239A$1.768,239D
Class A Common Stock11/13/2026S8,239D$2.0056(3)0D
Class A Common Stock11/13/2026M8,239A$1.778,239D
Class A Common Stock11/13/2026S8,239D$2.0056(3)0D
Class A Common Stock11/13/2026M8,239A$1.748,239D
Class A Common Stock11/13/2026S8,239D$2.0056(3)0D
Class A Common Stock11/13/2026M8,239A$1.618,239D
Class A Common Stock11/13/2026S8,239D$2.0056(3)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$1.6411/13/2026M8,24012/01/202312/01/2033Class A Common Stock8,240$00D
Stock Option (Right to Buy)$1.7611/13/2026M8,23911/01/202311/01/2033Class A Common Stock8,239$00D
Stock Option (Right to Buy)$1.7711/13/2026M8,23910/02/202310/02/2033Class A Common Stock8,239$00D
Stock Option (Right to Buy)$1.7411/13/2026M8,23901/02/202401/02/2034Class A Common Stock8,239$00D
Stock Option (Right to Buy)$1.6111/13/2026M8,23902/01/202402/01/2034Class A Common Stock8,239$00D
Explanation of Responses:
1. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.99 to $2.045 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. These securities are held by Mr. Varelas for the benefit of one or more entities affiliated with Riverwood Capital GP II Ltd. (collectively, "Riverwood"). Mr. Varelas is obligated to transfer such securities (or, in the case of an equity award, the shares underlying such award) or any proceeds from the sale thereof as directed by Riverwood. Mr. Varelas disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities by Mr. Varelas for purposes of Section 16 or any other purposes.
3. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.99 to $2.040 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ Sophia Contreras Schwartz, as Attorney-in-Fact for Reporting Person11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading